An interesting look at PitchBook's Data Analytics report outlining the trends and critical opportunities that will define the industry in years to come. 

Fierce Pharma’s initial field of 32 is down to the Sweet 16.

Eli Lilly’s diabetes med Mounjaro strolled to victory over Bristol Myers Squibb’s heart drug Camzyos by 72% to 28%.

Asking for a pay raise is no easy feat, and according to a study done by Indeed, it is particularly for women. When looking around the world more than half of women have never asked for a raise and of the 43% who asked, three in four received a pay increase.

Having peaked in 2021 and plummeted as the pandemic ended, deal value revived in 2023, with pharma companies pursuing growth and medtech companies chasing profitability. These trends promise to continue in 2024.

Take a look at this interesting report on Q1 2024 US Market Insights by PitchBook.

AbbVie’s CEO, Richard Gonzalez, has announced he will step down as CEO on July 1st. At that time, he will become Executive Chairman of the board, and AbbVie’s current President and COO, Robert Michael will take over his role. Gonzalez has served as AbbVie’s CEO for 11 years.

According to recent research by Ringover, a cloud-based telecom provider, which surveyed over 1,200 people who have interviewed job candidates, the quickest way to make a bad first impression in a job interview is to show up late.

The biopharma industry mergers and acquisitions in 2023 did not outdo the highs of 2019 but they did surpass 2022, 2021, and 2020 with $115.8 million in total. Topping the 2023 list is Pfizer’s $43 billion merger with Seagen.

Fierce Pharma has put together a list of the most anticipated drug launches based on Evaluate Vantage’s 2024 preview. Typically, major pharmaceutical and biotechnology companies are featured however, this year things could be a little different as the top pick is from a company that many may not know, Karuna Therapeutics.

Thanks to legislation that was put in place in 2023, more Americans can now get insulin for $35 as Sanofi, Novo Nordisk, and Eli Lilly have reduced pricing.

Here’s an interesting article on current public funding for Biotechs. Click here to read.

According to Erin McGofff, a New York City career expert, a phrase that can help set you apart from other interviewers is: “One thing that excites me about this role is ... .”

Inimmune Corporation and Intrommune Therapeutics, Inc have announced a collaboration to advance a clinical-stage oral mucosal therapy for those individuals with food allergies. The combination of treatments used by both companies could be a game changer for patients suffering from peanut allergies.

As partnerships in healthcare continue to increase in importance, industry specialists are collaborating to bring cutting-edge medical innovations and life-changing treatments to patients globally.

In this podcast, Paul Beresford, Vice President and General Manager of Companion Diagnostics (CDx)…

Maurice Schweitzer, a professor of management at Wharton, has researched what happens when people brag about themselves. Ideally, people want to come across as competent and likeable however, some people are seen as competent but not likeable.

An initial list of more than 250 talented women has been narrowed down to an impressive list of 10 of the fiercest women in life sciences. The women are from pharma, biotech, medtech, and venture capital, and all are powerhouses who are changing the face of leadership in life sciences.

Described as forward-thinking, courageous, and risk-takers, these 11 Innovation honorees, as noted by FiercePharma, are pushing the boundaries of what’s possible, driving change through cutting-edge technologies, processes, and ideas.

We all know that resumes should include language mirroring the job description, statistical proof of your accomplishments, and zero grammatical and spelling errors. What we are unsure of is to add some of your personality to your resume.

The National Comprehensive Cancer Network (NCCN) has reported that despite the FDA's efforts, chemo shortages persist stating that many treatment centers are lacking supplies of key medicines.

The Bandish Group has weathered many storms, yet emerges as a leader in the life sciences recruitment industry.